Genpact Limited (NYSE:G):
Genpact Launches an Artificial Intelligence (AI)-Based Solution to Usher in a New Era of Drug Safety Automation.
In the market the company is trading unchanged from yesterday’s close of $27.09.
The company also announced a dividend to be paid on Wednesday June 28th, 2017. The dividend payment will be $0.060 per share for the quarter which comes to $0.24 on an annualized basis. This dividend amount will represent a yeild of $0.89. The ex-dividend date will be Thursday the 8th of June 2017.
Genpact Limited, launched on March 29, 2007, is involved in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Business’s segments include Business process outsourcing and Information technology services. The Company offers various vertical activities, which include banking and financial services, capital markets, consumer product goods services, healthcare, infrastructure and manufacturing services, insurance and life sciences. In addition to these vertical activities, it also offers analytics and research, collections and customer services, consulting and transformation services, core industry operations services, enterprise application services, finance and accounting (F&A) services, information technology (IT) infrastructure management services, and supply chain and procurement services..
Shares last traded at $27.09 which is marginally higher than $26.01, the stock’s 50 day moving average and which is just over the 200 day moving average of $24.70. The 50 day moving average was up $1.08 or +4.14% and the 200 day average went up by +9.67%.
The P/E ratio is currently 21.28 and market capitalization is 5.22B. In the last earnings report the EPS was $1.27 and is estimated to be $1.55 for the current year with 192,743,000 shares currently outstanding. Analysts expect next quarter’s EPS to be $0.42 with next year’s EPS projected to be $1.73.
A few investment firms have issued ratings on the stock recently. Cowen & Company initiated coverage on G by announcing an initial rating of “Outperform”. On July 18 the company was downgraded from “Outperform” to “Market Perform” by BMO Capital.
Equity analyst SunTrust Robinson Humphrey issued its first research report on the stock with a rating of “Buy”. May 4 investment analysts at Citigroup held the stock rating at “Buy” and moved up the price target to $25.50 from $24.00.
On March 2 Deutsche Bank maintained a company rating of “Hold” and raised the price target from $19.00 to $21.00. February 5 investment analysts at Citigroup held the company rating at “Buy” but moved up the price target from $22.50 to $24.00.